BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+20.63%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$600M
AUM Growth
+$600M
(+5%)
Cap. Flow
-$66.1M
Cap. Flow
% of AUM
-11.01%
Top 10 Holdings %
Top 10 Hldgs %
85.23%
Holding
31
New
4
Increased
3
Reduced
10
Closed
3
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$13.3M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$5.62M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$4.39M |
| 4 |
TRVN
Trevena, Inc.
TRVN
|
$2.75M |
| 5 |
VXRT
Vaxart
VXRT
|
$2.66M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$35.6M |
| 2 |
Cytokinetics
CYTK
|
$21.5M |
| 3 |
Rigel Pharmaceuticals
RIGL
|
$20.8M |
| 4 |
Xencor
XNCR
|
$7.5M |
| 5 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$3.39M |
Sector Composition
| 1 | Healthcare | 77.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$3.15B
| $141M | 21.86% | 2,096,416 -529,744 | -20% | -$35.6M |
|
2
Ironwood Pharmaceuticals
IRWD
$214M
| $115M | 17.77% | 9,303,003 -272,646 | -3% | -$3.36M |
|
|
CCXI
3
DELISTED
ChemoCentryx, Inc.
CCXI
| $51.7M | 8.01% | 7,796,516 | – | – |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $39.9M | 6.18% | 8,486,927 +933,838 | +12% | +$4.39M |
|
|
OMED
5
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $33.3M | 5.16% | 989,778 -100,700 | -9% | -$3.39M |
|
6
Gyre Therapeutics
GYRE
$703M
| $29.3M | 4.54% | 6,171,669 | – | – |
|
|
CASC
7
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $26.9M | 4.17% | 9,001,778 | – | – |
|
|
FPRX
8
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $22.3M | 3.46% | 1,136,000 +675,000 | +146% | +$13.3M |
|
|
TBRA
9
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $20.8M | 3.22% | 1,659,091 | – | – |
|
|
RCPT
10
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $18.9M | 2.93% | 450,800 +134,108 | +42% | +$5.62M |
|
|
QLTI
11
DELISTED
QLT Inc
QLTI
| $13.2M | 2.04% | 2,370,263 | – | – |
|
|
12
Rigel Pharmaceuticals
RIGL
$697M
| $10M | 1.55% | 2,576,707 -5,366,508 | -68% | -$20.8M |
|
|
ARQL
13
DELISTED
Arqule Inc
ARQL
| $5.02M | 0.78% | 2,449,387 -375,000 | -13% | -$769K |
|
|
PTN
14
DELISTED
Palatin Technologies
PTN
| $3.46M | 0.54% | 2,809,824 -2,390,176 | -46% | -$2.94M |
|
|
TRVN
15
DELISTED
Trevena, Inc.
TRVN
| $2.75M | 0.43% | +350,000 | New | +$2.75M |
|
|
VXRT
16
DELISTED
Vaxart
VXRT
| $2.66M | 0.41% | +435,900 | New | +$2.66M |
|
|
SPHS
17
DELISTED
Sophiris Bio, Inc.
SPHS
| $2M | 0.31% | 600,000 | – | – |
|
|
AKAO
18
DELISTED
Achaogen, Inc.
AKAO
| $1.93M | 0.3% | +125,000 | New | +$1.93M |
|
|
ANTH
19
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.88M | 0.29% | 559,624 | – | – |
|
|
BLRX
20
BioLineRX
BLRX
$16.2M
| $1.78M | 0.28% | +800,000 | New | +$1.78M |
|
|
RGLS
21
DELISTED
Regulus Therapeutics
RGLS
| $1.67M | 0.26% | 184,999 -48,690 | -21% | -$439K |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.43M | 0.22% | 74,900 -59,417 | -44% | -$1.13M |
|
|
BIND
23
DELISTED
BIND THERAPEUTICS INC
BIND
| $1.39M | 0.22% | 116,000 -34,000 | -23% | -$407K |
|
|
24
Cytokinetics
CYTK
$4.23B
| $1M | 0.16% | 105,705 -2,263,200 | -96% | -$21.5M |
|
|
PRTK
25
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $462K | 0.07% | 150,000 | – | – |
|